Sublime Therapeutics' Seed Round

Sublime Therapeutics raised a round of funding on December 19, 2017. Investors include Berkeley SkyDeck.

Sublime Therapeutics is a privately held biotechnology company based in the San Francisco Bay Area focused on developing proprietary anti-gastrin technology to address significant unmet medical needs …

Articles about Sublime Therapeutics' Seed Round: